He did not say what he would do about foreign online pharmacies, which may pose bigger problems because they are less likely to demand a prescription before selling drugs to Americans.
Findings from our evaluation provide insight into possible barriers to setting up services in pharmacies which may help other commissioning bodies when considering community pharmacy as a location for primary prevention interventions in future.
The sales data are only sourced from one supermarket chain, and while that chain has one of the largest market shares nationally in the UK, many non-prescription purchases are likely to be made in other outlets (such as dedicated pharmacies) which may better reflect community incidence of infection.
The results of this study provide much needed information to the naturopathic, WHM and pharmacy communities which may benefit from each others expertise in the community pharmacy setting.
Adherence indicators can be constructed from pharmacy data, which may be easily useful to identify patients who need assistance with medication adherence [ 43].
While some studies have shown that ertapenem use was not associated with carbapenem-resistant Pseudomonas aeruginosa, these only looked at pharmacy purchasing databases, which may not necessarily reflect actual ertapenem prescription [ 7- 10].
When health care providers offer this service, the step of visiting the pharmacy is eliminated, which may be important when the patient has little money or wishes to maintain confidentiality about his or her drug use.
Another issue concerning the use of PBS records in this study is that it is possible to buy inhaled SABs 'over the counter' from pharmacies in WA, which may make the findings of worse survival in the lowest pharmacotherapy level to appear to be due to less access to care.
Demand-side regulations and incentives can aim at physician prescribing behaviour or pharmacy dispensing patterns [17], which may include financial or non-financial incentives [26].
Although interchangeability will be determined by the FDA, the regulation of therapeutic interchange and automatic substitution is controlled by state pharmacy boards and state laws, which may vary between states 1, 29.
